The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who have not received the vaccine for the cancer.

Peter Yarrow, one-third of the hit-making 1960s folk group Peter, Paul and Mary, and a Jewish activist who promoted Israeli-Palestinian coexistence and other progressive causes, died Tuesday at age 86.

A new report from the outgoing U.S. surgeon general warns about the cancer risk associated with drinking alcohol — and it comes at a time when a so-called “sober curious” movement is already brewing culturally.

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or returning when treated with immunosurpressant drug durvalumab, and were more likely to still be alive two years after treatment.

Bladder cancer patients given an immunotherapy drug are a third less likely to see disease come back and are more likely to survive, according to a 'game-changer' study. Patients with advanced ...

The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% [101] Association of CK19 with UPII detected pN0 patients with ...